About Primary hyperaldosteronism-seizures-neurological abnormalities syndrome
Primary hyperaldosteronism-seizures-neurological abnormalities syndrome is a rare disease catalogued by Orphanet (ORPHA:369929). It is associated with the CACNA1D gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Primary hyperaldosteronism-seizures-neurological abnormalities syndrome trials.
Search ClinicalTrials.gov for "Primary hyperaldosteronism-seizures-neurological abnormalities syndrome" or filter by Orphanet code ORPHA:369929 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Primary hyperaldosteronism-seizures-neurological abnormalities syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Primary hyperaldosteronism-seizures-neurological abnormalities syndrome. Updated daily.